Propranolol en hemangiomas infantiles: eficacia clínica, riesgos y recomendaciones
Authors:
- I. Sánchez-CarpinteroISI. Sánchez-Carpintero
- R. Ruiz-RodriguezRRR. Ruiz-Rodriguez
- J.C. López-GutiérrezJLJ.C. López-Gutiérrez
- 1 December 2011
- journal article
- abstracts
- Published by Elsevier in Actas Dermo-Sifiliograficas
- Vol. 102 (10) , 766-779
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Hypoglycemia as a Result of Propranolol During Treatment of Infantile Hemangioma: A Case ReportPediatric Dermatology, 2011
- Study protocol: safety and efficacy of propranolol in newborns with Retinopathy of Prematurity (PROP-ROP): ISRCTN18523491BMC Pediatrics, 2010
- Propranolol in the management of periorbital infantile haemangiomaClinical & Experimental Ophthalmology, 2010
- A Randomized Trial of Propranolol versus Sodium Valproate for the Prophylaxis of Migraine in Pediatric PatientsPediatric Drugs, 2010
- Efficacy of Propranolol in Hepatic Infantile Hemangiomas with Diffuse Neonatal HemangiomatosisThe Journal of Pediatrics, 2010
- Massive response of severe infantile hepatic hemangioma to propanololPediatric Blood & Cancer, 2009
- A prospective study of PHACE syndrome in infantile hemangiomas: Demographic features, clinical findings, and complicationsAmerican Journal of Medical Genetics Part A, 2006
- Ultrapotent topical corticosteroid treatment of hemangiomas of infancyJournal of the American Academy of Dermatology, 2005
- Characterization of Fatal Beta Blocker Ingestion: A Review of the American Association of Poison Control Centers Data from 1985 to 1995Journal of Toxicology: Clinical Toxicology, 1997
- Hepatic vascular anomalies in infancy: A twenty-seven-year experienceThe Journal of Pediatrics, 1996